I think we can break down the trials into the following with respect to cardioprotection and FTO inhibition:
1. Are the patients getting positive outcome (cancer/ symptom reduction) from the treatment and are the side effects as expected or below known adverse events.
2. Is that due to cardio protection and/ or FTO inhibition? How can we prove it?
3. Is it significant enough?
4. Are there any doubts in terms of safety, efficacy or the contribution of Bisantrene to the patient outcomes?
Anything else?
- Forums
- ASX - By Stock
- RAC
- Cardioprotection thread
Cardioprotection thread, page-437
- There are more pages in this discussion • 118 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.45 |
Change
-0.005(0.34%) |
Mkt cap ! $242.5M |
Open | High | Low | Value | Volume |
$1.46 | $1.50 | $1.43 | $62.91K | 43.17K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 5700 | $1.43 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.45 | 591 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 5700 | 1.430 |
3 | 13542 | 1.420 |
2 | 20700 | 1.410 |
1 | 3500 | 1.405 |
6 | 25737 | 1.400 |
Price($) | Vol. | No. |
---|---|---|
1.450 | 591 | 1 |
1.500 | 7000 | 1 |
1.510 | 2408 | 1 |
1.540 | 10000 | 1 |
1.550 | 26171 | 3 |
Last trade - 16.10pm 24/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.46 |
  |
Change
-0.005 ( 0.23 %) |
|||
Open | High | Low | Volume | ||
$1.44 | $1.49 | $1.43 | 9034 | ||
Last updated 13.08pm 24/05/2024 ? |
Featured News
RAC (ASX) Chart |